Clinical Report: Evaluating the Role of Artificial Intelligence in Radiologic Diagnosis of Ductal Carcinoma In Situ
Overview
This comprehensive review evaluates the role of artificial intelligence (AI) in enhancing the radiologic diagnosis of ductal carcinoma in situ (DCIS).
Background
Ductal carcinoma in situ (DCIS) represents a significant proportion of breast cancer diagnoses, with a notable risk of progression to invasive cancer. The limitations of traditional imaging modalities, particularly in dense breast tissue, highlight the need for improved diagnostic tools. AI has emerged as a potential solution to enhance the accuracy and efficiency of DCIS detection and management.
Data Highlights
Metric
Value
AUC
0.70 to 0.97
Sensitivity
80–96%
Specificity
up to 93%
Key Findings
AI technologies can enhance detection and classification of DCIS.
AI models demonstrate AUCs ranging from 0.70 to 0.97.
Sensitivities for AI in DCIS detection range from 80% to 96%.
Specificities for AI can reach up to 93%.
Temporal, multiphase, and spatially aware models outperform conventional 2D approaches.
Limitations include retrospective designs and generalizability concerns.
Clinical Implications
Further validation and standardization of AI tools are necessary to ensure their clinical applicability.
Conclusion
Careful consideration of AI's limitations and the need for further research is essential.
